Antibody-based HLA (Human Leucocyte Antigen ) tissue-typing technologies

Similar documents
The country of origin for FBS refers to country in which the raw blood was collected.

Frequently Asked Questions (FAQs): FBS

BLOOD FRACTIONATION FOR IVD

Osteobiologic B O N E G R A F T I N G S O L U T I O N S

Topics. GIBCO Sera. Vertically Integrated Manufacturing Process. Proprietary BVDV Screening Program. ISIA Traceability Certified

Aim. To provide basic knowledge on the processing, testing and issue of blood donations by NHSBT

Gibco cell culture sera for bioprocessing

Bovine Serum Albumin (BSA) Fraction V

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)

Regulatory Challenges for the Development of Allogeneic Mesenchymal Stem Cell Products. Rod Monroy, Ph.D. Director, Prochymal

Raw Materials: Sourcing and Qualification Testing

PART 610 GENERAL BIOLOGICAL PRODUCTS STANDARDS. Subpart A Release Requirements. 21 CFR Ch. I ( Edition) Subpart G Labeling Standards

CELL CULTURE. Fetal Bovine Serum product line. Quality Value Service

Outcomes in Mesenchymal Stem Cell Manufacturing. Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL

Bovine Serum Albumin (BSA), Product Sheet

4006: Cellular Therapy Infusion

Product Testing & Release. PACT Workshop: Design & Operation of GMP Cell Therapy Facilities April 10 th /11 th, 2007

Irish Blood Transfusion Service Seirbhís Fuilaistriúcháin na héireann

Liquid. This product is shipped with dry ice. Upon receipt, store it immediately at the temperature recommended below.

Atlanta Biologicals Fetal Bovine Serum. and Cell Culture Media & Reagents

Human Adult Mammary Fibroblast Care Manual

Form 4006 R1.0: Cellular Therapy Infusion

Quality of raw materials and manufacturing of advanced therapies. Fouad Atouf, Ph.D. Head, Global Biologics July 12, 2018

LIFECODES HLA Typing Tray Class I (ABC) ABC1/ABC2 (Australia)

Food and Drug Administration, HHS Pt. 610

PRO-STIM Injectable Inductive Graft Containing DONATED HUMAN TISSUE

Human Tenocyte Care Manual

PRO-STIM Injectable Inductive Graft Containing DONATED HUMAN TISSUE

Clonetics Skeletal Muscle Myoblast Cell Systems HSMM Instructions for Use

Cyfra 21-1 IRMA. Product information Information about other products is available at: Userś Manual DE52100

HANDLING INSTRUCTIONS

FROM CONCEPT TO PATIENT TREATMENT: A CLINICAL TRIAL OF MESENCHYMAL STROMAL CELLS FOR AMYOTROPHIC LATERAL SCLEROSIS

Expert in biological products of human origin BLOOD PRODUCTS STABLE PRODUCTS STEM CELLS HUMAN TISSUES MOTHER S MILK

ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development

Mesenchymal Stem Cells

A Life Cycle Approach to Raw Material Qualification for Cell and Gene Therapy Products

CMC Considerations for Manufacturing of CAR T-Cell Product

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications

True Confessions: Ancillary Materials in a Cell Processing Lab. Cell Processing Section, DTM, CC, NIH David Stroncek, MD Chief, CPS, DTM, CC

ScienCell. Human Epidermal Keratinocytes-adult (HEK-a) Catalog Number: Research Laboratories

Date. Albumin measurements are used in the diagnosis and treatment of numerous diseases primarily involving the liver and/or kidneys.

Form 4006 R2.0: Cellular Therapy Infusion

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

Hepatitis C virus Ab ELISA Kit

Current Considerations on Chemistry, Manufacturing and Control of Cell Therapy Products (CTPs)

PIC/S GMP GUIDE FOR BLOOD ESTABLISHMENTS

Considerations in Product Development with Advanced Therapies and Cancer Vaccines

AAG PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

Supplemental Information

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

Adoptive cellular therapies are based on the administration of live cells into a patient in order for them to serve a therapeutic purpose.

Human Splenocyte Cell Care Manual

Human Tissue Intended for Transplantation Skin, corneas, sclera, bone, heart valves, blood vessels, pericardium, tendons, cartilage, fascia

Cell Processing at CAGT. Overview. Adrian P. Gee Center for Cell & Gene Therapy. CAGT Introduction

APB PRINCIPLE SPECIMEN. REF (300 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

HUMAN CYTOGENETICS.

FDA Approach to the Regulation of Hematopoietic Stem/Progenitor Cells (HPC)

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON

CARE MANUAL INSTRUCTIONAL MANUAL ZBM SHIPPING CONDITIONS STORAGE CONDITIONS ORDERING INFORMATION AND TECHNICAL SERVICES

Classification under the IVD Regulation

Supplies and Reagents

Excipient Albumin CSL Behring Human Serum Albumin

ASSESSING THE EFFICACY AND SAFETY OF NORMAL INTRAVENOUS IMMUNOGLOBULIN PRODUCTS FOR MARKETING AUTHORISATIONS

FDA Perspective on Plasma Quality and GMPs

PRINCIPLE SPECIMEN. REF (300 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

Human Dermal Fibroblast Manual

Human IFN-γ. Pre-Coated ELISA Kit

Supplies and Reagents

Blood Product Utilization

Contact details: Anna Silvani

OIE Guideline. International Reference Antibody Standards for Antibody Assays. 1. Introduction

Paul Ashford Executive Director ICCBBA

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) POINTS TO CONSIDER ON SAFETY OF HOMEOPATHIC MEDICINAL PRODUCTS FROM BIOLOGICAL ORIGIN

Acetylcholine Receptor Ab ELISA Kit

Influenza A IgG ELISA

Lab Partner for Life Cell Culture Products

Product Testing & Release. PACT Workshop: Design & Operation of GMP Cell Therapy Facilities April 4 th /5 th, 2006

FACT Inspector Standards Review Questions 5 th Edition Cord Blood Standards

HHV-6 IgG ELISA Kit. Cat.No: DEIA3565 Lot. No. (See product label) Size. Intended Use. General Description. Principle Of The Test

INSTRUCTIONS FOR USE. BLOOD GROUPING REAGENT ORTHO Sera Anti-Le a (Anti-LE1) ORTHO Sera Anti-Le b (Anti-LE2)

Bovine IgG-Ab ELISA Kit

Introduction. Foetal Bovine Sera (FBS) Bovine Sera. Other Sera

Ancillary Materials for Cell & Tissue Therapies Definitions, US Regulatory Approach, and USP s Risk-Tiered Approach

AAT PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

ABOUT GLYCOSTEM. Company Overview

Luteinizing Hormone ELISA kit

Hematopoietic Stem Cells: Cell Processing, and Transplantation

CONDITIONS AND PROCEDURES FOR IMPORTATION AND EXPORTATION

PAB PRINCIPLE. Kit Reorder # ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

Stem Cells, Regenerative Medicine and cgmp (GTP)

FDA Update. Scott A. Brubaker, CTBS Director, Division of Human Tissues Office of Tissues and Advanced Therapies CBER/FDA

POL:07:QP:010:03:NIBT PAGE: 1 of 4. Document Details Document Number: POL:07:QP:010:03:NIBT No. of Appendices: 4 Supersedes Number: 07:02:QP:010:NIBT

Product Information. BioWhittaker Lymphochrome X5-Box 10 x 5 ml

Biotechnology of Human Plasma-Derived Medicines in Scope of Collaboration Perspectives within The Central European Initiative

Human IFN-α (Interferon-Alpha) Pre-Coated ELISA Kit

For In Vitro Diagnostic Use

See external label 2 C-8 C = ANTISTREPTOLYSIN O (ASO) REAGENT SET A LATEX SLIDE TEST

STANDARDS FOR HEMATOPOIETIC PROGENITOR CELL COLLECTION, PROCESSING & TRANSPLANTATION

EZXpand TM Umbilical Vein Endothelial Cell Culture Kit

Transcription:

Human AB Serum Product Description Human AB Serum is a vital cell culture reagent for some human cell types providing growth factors, vitamins, nutrients as well as trace elements and transport factors, ensuring faster growth rates than mixed blood group serum. Human AB is proven to grow many human cell lines at a faster rate and with a smaller percentage of serum than mixed blood group serum 1-9. Human AB serum is now widely used in a variety of Cell Therapy applications. There are two types of Human AB serum commercially available: Converted serum is produced by defibrinating pooled human plasma that was collected via plasmapheresis, in the presence of an anticoagulant such as sodium citrate. Defibrination is achieved through the use of bovine thrombin. This material is also referred to as Plasma-derived. Off-clot serum is collected from blood that is allowed to coagulate naturally after collection, in the absence of any anticoagulant. Human serum from type AB donors lacks antibodies against the A and B blood-type antigens and is therefore commonly used when there is the need to minimize immunoreactivity. Furthermore, male only serum is especially advantageous compared with female or mixed gender serum, because there is no risk of the presence of antibodies against major histocompatibility class (MHC) antigens, that can be produced by female donors against antigens carried on the father s cells and/or the foetus cells during pregnancy. Applications Human serum provides a more comparable cell culture environment compared with other animal sera such as Foetal Bovine Serum (FBS). It is the serum of choice when working with immune cells like lymphocytes and macrophages. In addition, the use of human serum may be necessary in order to meet regulatory requirements on the use of animal derived material. Transplantation and cell therapy applications for the expansion of mesenchymal stem cells (MSC) from adipose tissue or mesenchymal stromal cells from human bone marrow For ex vivo expansion of NK cells from peripheral blood in Haematopoeitic Stem Cell Expansion Medium For upgrading pre-transplant human islet culture technology Tissue engineering Antibody-based HLA (Human Leucocyte Antigen ) tissue-typing technologies For standardized limbal epithelial stem cell graft generation and transplantation Tissue culture of human cell lines Serological typing and as a blocking agent Page 1 of 6

Donor Qualification and Testing US origin Human AB serum is collected from healthy volunteer male donors of the AB serotype at FDA-licensed facilities in the United States and collected in compliance with health requirements established by 21CFR 640, subpart G. All approved donor units are also tested according to testing requirements for communicable disease agents as stated in 21 CFR 610.40. All units are negative (non-reactive) for HBsAG (Hepatitis B Surface Antigen), HIV-1/2 (Human Immunodeficiency Virus Type 1 and 2), and HCV (Hepatitis C Virus) and syphilis using FDA approved methods. The final pool is also tested for HCV RNA, HBV (Hepatitis B Virus) DNA, HTLV-1/2 (Human T-Lymphotropic Virus) and HIV-1 RNA. Converted serum is routinely screened for the presence of animal contaminants. This is performed by DNA analysis. French origin Human AB serum is collected from healthy volunteer male donors of the AB serotype at EU registered facilities. The material is CE marked and ANSM approved IVDMD. All units are negative (non-reactive) for HBsAG (Hepatitis B Surface Antigen), HIV-1/2 (Human Immunodeficiency Virus Type 1 and 2), and HCV (Hepatitis C Virus) RNA, HTLV-1/2 (Human T-Lymphotropic Virus), HIV-1 RNA and syphilis. No Animal derived ingredients (ADI) are used in the production of Human AB serum. The manufacturing process does not use any ingredient of animal origin. Specifications US origin Off-Clot material typically requires 200-250 pre-screened donors per batch. Each individual donation can produce approximately 200 ml serum. Human AB serum produced from converted plasma may be manufactured from a pool of material from a maximum of 10 donors. It offers a more reproducible product with a reduced potential risk of cross infection. French origin Serum only available as off-clot material. Country of Origin US origin, Male only donors. French origin, Male only donors. Sterility Viral Testing Each batch of sera is tested for the absence of bacteria, fungi, yeast and Mycoplasma. All donor units that go into making each batch, are tested for HBsAG, anti-hcv, anti-hiv1 and 2, HIV-1, and Syphilis. Each batch of sera is tested for the absence of bacteria, fungi, yeast and Mycoplasma. All donor units that go into making each batch, are tested for HBsAG, anti-hcv, anti-hiv1 and 2, HIV-1, and Syphilis. Endotoxin All sera are tested to determine the levels of endotoxins using the Limulus amebocyte lysate test (LAL). All sera are tested to determine the presence of endotoxins. Page 2 of 6

Mycoplasma Tested for M. pneumonia, M. hominis and M. salivarium. Growth promotion Biological performance of final batches of sera is assessed by cell culture in Jurkatt cells. Tested. Not tested. Filtration Final batches of sera are filtered to 0.1 µm to ensure sterility before being dispensed, aseptically into sterile bottles. Final batches of sera are filtered to 0.2 µm to ensure sterility before being dispensed, aseptically into sterile bottles. Presentation Life Science Production recognises the need for flexibility in the production of Human AB for cell therapy applications. Human AB may be supplied in any bottle size e.g. 1 litre,,,, 25 ml, as required, including bottles fitted with septums for the aseptic removal of serum. Human AB serum may also be processed into single use bags with tubing sets to meet individual production requirements. For further information concerning bespoke packaging requirements, please contact info@lifesciencegoup.co.uk for further information. Product Information Product Code Product Description Pack Size S-101A-US S-101B-US S-101C-US S-101C-US-SEP S-102A-US S-102B-US S-102C-US S-103A-US S-103B-US S-103C-US S-104A-US, supplied in bottle with Septum Human AB Serum, Male only, Converted, US Origin, sterile filtered 0.1 * Human AB Serum, Male only, Converted, US Origin, sterile filtered 0.1 * Human AB Serum, Male only, Converted, US Origin, sterile filtered 0.1 * micron Manufacturing GradeƗ micron Manufacturing GradeƗ micron Manufacturing GradeƗ Human AB Serum, Male only, Converted, sterile filtered 0.1 micron Manufacturing Grade*Ɨ Page 3 of 6

S-104B-US S-104C-US S-101A-EU S-101B-EU S-101C-EU S-101-C-EU-SEP Human AB Serum, Male only, Converted, sterile filtered 0.1 micron Manufacturing Grade*Ɨ Human AB Serum, Male only, Converted, sterile filtered 0.1 micron Manufacturing Grade*Ɨ Human AB Serum, Male only, off clot, EU Origin, sterile filtered 0.2 Human AB Serum, Male only, off clot, EU Origin, sterile filtered 0.2 Human AB Serum, Male only, off clot, EU Origin, sterile filtered 0.2 Human AB Serum, Male only, off clot, EU Origin, sterile filtered, 0.1, supplied in bottle with Septum 50 ml * Product has been converted from plasma, using bovine thrombin. Ɨ Manufacturing grade also offers enhanced donor traceability and additional viral testing. Quality Each batch of Human AB is subjected to rigorous control from the point of collection, through testing of individual donor units and subsequent processing Human AB is produced in batches of typically 1-100 litres, sterile filtered to 0.1 micron. Sera is tested for the absence of bacteria, fungi, yeast and Mycoplasma. All donor units that form each batch are tested for HBsAG, anti-hcv, anti-hiv1 and 2, HIV-1, and Syphilis. Additional viral testing on both individual donors and pooled material is available to meet current regulatory standards for further manufacturing. Presentation Human AB serum can also be supplied in different presentations including individual supplier packs. Human AB serum is normally supplied in bottles, although other presentations are available on request such as smaller volumes (e.g., 25 ml). APS are also able to offer special presentations such as material supplied in single dose bags. Batch Sampling LSP offer samples of Human AB for testing prior to selection of a suitable batch. Typical sample size is 25 ml and reservations are held for a period of four weeks, pending evaluation. Additional Treatment Human AB serum is also available heat inactivated, gamma irradiated, charcoal stripped and dialysed. Shelf life Human AB serum has a shelf life of 5 years from the date of manufacture, provided it is stored appropriately. We would recommend enquiring about the shelf life of each available batch if it is important to have a long shelf life following purchase. Page 4 of 6

Storage & Handling Recommended storage is -20 C or below. It is recommended to avoid freeze-thaw cycles as this can lead to a deterioration in serum qualities. Ideally, material should be thawed under controlled conditions and re-aliquoted into smaller volumes before re-freezing. It is not recommended to store or refreeze partially used serum as degradation is rapid if microbial contamination occurs. All biological material should be handled as potentially infectious. It is essential that universal precautions should be employed when handling all Human AB serum. Please note: whilst it is possible to perceive differences in the appearance of different batches of human serum, APS goes to great lengths to ensure that the collection and handling process result in a highly consistent product. Differences in appearance can be largely attributed to the variation in human diet, and in particular to dietary fats. In addition, slight differences in appearance can result from the inconsistent storage and/or handling of the material once in the laboratory. Since human serum is especially sensitive compared with other sources of serum, it is essential that particular attention be paid to the care and handling of the material. Shipping Product ships frozen on dry ice. Literature 1. Cánovas, D., and Bird, N., (2012) Letter: Human AB serum as an alternative to fetal bovine serum for endothelial and cancer cell culture. Altex, 29(4): 426-428. 2. Chimenti, I., et al. (2014) Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture. J. Cell. Mol. Med., 18(4): 624 634. 3. Dahl, J. A., et al. (2008) Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int. J. Dev. Biol., 52(8): 1033 1042. 4. Jung, S., et al. (2012) Ex Vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int., 2012 Article ID 123030, doi:10.1155/2012/123030. 5. Kocaoemer, A., et al. (2007) Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of Mesenchymal Stem Cells from adipose tissue. Stem Cells, 25(5): 1270-1278. 6. Le Blanc, K., et al. (2007) Generation of immunosuppressive Mesenchymal Stem Cells in allogeneic Human Serum. Transplantation, 84(8): 1055-1059. 7. Lindroos, B., et al. (2010) Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. Tissue Eng. Part A, 16(7): 2281-2294, DOI: 10.1089/ten.tea.2009.0621. 8. Paloni, A., et al. (2009) Selection of CD271+ cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow. Cytotherapy, 11(2): 153-162. 9. Shahdadfar, A., et al. (2005) In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells, 23(9): 1357 1366. Page 5 of 6

10. Stute, N., et al. (2004) Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp. Hematol., 32(12): 1212 1225. Precaution All Human serum products have been thoroughly tested to strict guidelines. However, while all of the human donors that go into producing each batch of human serum have been tested and have been found negative for several virus antibodies and antigens, there is no known test method can offer complete assurance that human derived blood products are not capable of transmitting an infectious disease. It is therefore important that human serum be considered potentially infectious and handled accordingly. Support Life Science Production is a division of Life Science Group Ltd. Life Science Production is ISIA Traceability Certified To learn more, contact us: Telephone: +44 (0) 1234 889180 Email: sales@lifesciencegroup.co.uk Website: www.lifesciencegroup.co.uk Address: PO Box 1519, Bedford, United Kingdom Page 6 of 6